evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
13087,GENE_BACKGROUND,,"The NFκBIα (NF-κB inhibitor α) gene encodes a protein that represses signaling of NF-κB, a family of transcription factors activated by the epidermal growth factor receptor (EGFR) pathway. NFκBIα helps keep NFκB in an inactive state by supporting its interaction with inhibitory molecules in the cell cytoplasm. A range of external stimuli, including pro-inflammatory cytokines, growth factors or stress, can lead to phosphorylation of NFκBIα and subsequently the release and nuclear translocation of NFκB; this results in the transcriptional activation of hundreds of genes that regulate the immune response, protect against apoptosis and signaling pathways critical to the formation of ectodermal tissues. Lack of NFκB is often due to loss-of-function mutations (small insertions, deletions, or missense) in one allele of NFκBIα coupled with deletion or inactivation of the second allele (PMID: 9572494). Constitutive expression of NF-κB signaling results in overexpression of several target genes encoding anti-apoptotic proteins and growth-promoting proteins (PMID: 11313274). Deletion of NFκBIA has demonstrated an effect similar to EGFR amplification in glioblastomas (GBM) and is associated with relatively reduced survival (PMID: 21175304). Further, enrichment of single-nucleotide polymorphisms (SNPs) and mutations in NFκBIA have been observed in Hodgkin’s lymphoma (PMID: 10023670, 19507254), colorectal cancer (PMID: 17354114), melanoma (PMID: 17492467), hepatocellular carcinoma (PMID: 19797428), breast cancer (PMID: 16959974) and multiple myeloma (PMID: 16540234).",,2017-04-06,,4792,NFKBIA,NFKB inhibitor alpha,True,ENST00000216797,NM_020529.2,IKBA,NFKBI,MAD-3,False,16959974,The consensus coding sequences of human breast and colorectal cancers.,"Science (New York, N.Y.)",2018-10-13T20:06:00,314,5797,268-74,Sjöblom T et al,,,0001-10-13,,16540234,Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma.,Cancer letters,2018-02-08T20:07:00,246,2001-01-02,1992-09-01,Spink CF et al,,,2002-01-02,,11313274,"Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.",Blood,2018-05-01T20:01:00,97,9,2798-807,Hinz M et al,,,2018-05-01T08:07:00,,17492467,"Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.",Journal of cancer research and clinical oncology,2018-11-01T20:07:00,133,11,859-66,Bu H et al,,,0001-11-01,,21175304,NFKBIA deletion in glioblastomas.,The New England journal of medicine,2018-02-17T20:11:00,364,7,627-37,Bredel M et al,doi: 10.1056/NEJMoa1006312,,0001-02-17,,19797428,IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.,Carcinogenesis,2018-11-01T20:09:00,30,11,1916-22,He Y et al,doi: 10.1093/carcin/bgp226,,0001-11-01,,10023670,Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.,Oncogene,0001-01-28,18,4,943-53,Krappmann D et al,,,0001-01-28,,17354114,Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations.,Scandinavian journal of gastroenterology,2018-03-01T20:07:00,42,3,345-50,Gao J et al,,,0001-03-01,,19507254,"Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.",International journal of cancer,2018-09-15T20:09:00,125,6,1334-42,Lake A et al,doi: 10.1002/ijc.24502,,0001-09-15,,9572494,Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.,Oncogene,0001-04-23,16,16,2131-9,Wood KM et al,,,0001-04-23,
13086,GENE_SUMMARY,,NFκBIα encodes a negative regulator of the NF-κB and consequently EGFR pathways.,,2017-04-06,,4792,NFKBIA,NFKB inhibitor alpha,True,ENST00000216797,NM_020529.2,IKBA,NFKBI,MAD-3,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
